Health and Fitness Health and Fitness
Thu, September 2, 2010
[ Thu, Sep 02nd 2010 ] - Market Wire
HealthSpring, Inc. to Present at the Stifel Nicolaus Healthcare Conference
[ Thu, Sep 02nd 2010 ] - Market Wire
American HomePatient Announces Successful Results of Self-Tender Offer and Debt Restructuring
[ Thu, Sep 02nd 2010 ] - Market Wire
Seattle Genetics Achieves Milestone under Antibod .. laboration with Agensys, an Affiliate of Astellas
[ Thu, Sep 02nd 2010 ] - Market Wire
Humana Names Stephen Macias Specialty Market President in Northern California
[ Thu, Sep 02nd 2010 ] - Market Wire
Cardiome Achieves $30 Million Milestone
[ Thu, Sep 02nd 2010 ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Randomized P .. to be Conducted by the Gynecologic Oncology Group
[ Thu, Sep 02nd 2010 ] - Market Wire
NUVO RESEARCH TO PRESENT AT RODMAN &; RENSHAW 12TH ANNUAL HEALTHCARE CONFERENCE
[ Thu, Sep 02nd 2010 ] - Market Wire
Gilead geeft update over aandelenterugkoop van 5 miljard dollar
[ Thu, Sep 02nd 2010 ] - Market Wire
AVEO Pharmaceuticals, Inc. to Present at Several Upcoming Investment Conferences
[ Thu, Sep 02nd 2010 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September
[ Thu, Sep 02nd 2010 ] - Market Wire
BRINAVESSa" (Vernakalant) zur Infusion erhlt Zula .. n fr rapide Konversion von krzlich begonnenem Vor
[ Thu, Sep 02nd 2010 ] - Market Wire
MedPro Safety Products Completes Royalty Monetization Transaction
[ Thu, Sep 02nd 2010 ] - Market Wire
Rosetta Genomics to Host Second Quarter 2010 Conference Call on Wednesday, September 8, 2010
[ Thu, Sep 02nd 2010 ] - Market Wire
RegeneRx Appoints R. Don Elsey to Board of Directors
[ Thu, Sep 02nd 2010 ] - Market Wire
Transdel Pharmaceuticals Presents Phase 3 Study D .. sdel® at World Pain Congress in Montreal, Canada
[ Thu, Sep 02nd 2010 ] - Market Wire
La divisione di KCI LifeCella" Corporation e Nova .. contratto di vendita e marketing per la distribu
Wed, September 1, 2010
[ Wed, Sep 01st 2010 ] - Market Wire
Southpoint holdings in Adherex Technologies Inc. (TSX: AHX)
[ Wed, Sep 01st 2010 ] - Market Wire
CENTRIC HEALTH INVESTS IN HOMECARE THROUGH ACQUIS .. LEADING COMMUNITY REHABILITATION SERVICES COMPANY
[ Wed, Sep 01st 2010 ] - Market Wire
BRINAVESSa" (vernakalant) for Infusion Approved i .. id Conversion of Recent Onset Atrial Fibrillation
[ Wed, Sep 01st 2010 ] - Market Wire
Angeion Restructures Board; Names New Members
[ Wed, Sep 01st 2010 ] - Market Wire
Orthovita to Present at the Stifel Nicolaus 2010 Healthcare Conference
[ Wed, Sep 01st 2010 ] - Market Wire
Vascular Solutions to Present at the 2010 Stifel Nicolaus Healthcare Conference
[ Wed, Sep 01st 2010 ] - Market Wire
InSite Vision to Present at Rodman & Renshaw 12th Annual Healthcare Conference
[ Wed, Sep 01st 2010 ] - Market Wire
St. Jude Medical To Present at the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 01st 2010 ] - Market Wire
Zacks Releases Four Powerful ''Buy'' Stocks: Mage .. arfums, Aliance Resource Partners LP and Sotheby'
[ Wed, Sep 01st 2010 ] - Market Wire
Neuigkeiten zu Gileads 5 Milliarden Dollar schwerem Aktienrckkaufprogramm
[ Wed, Sep 01st 2010 ] - Market Wire
IntraOp Medical Corporation Announces Purchase of Two Next Generation Mobetrons by UCSF
[ Wed, Sep 01st 2010 ] - Market Wire
CORRECTING and REPLACING Kim A. Keck to Lead Aetnaa?s Middle Markets Business
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien maakt agenda investeerdersvergadering bekend
[ Wed, Sep 01st 2010 ] - Market Wire
Gilead presenta ltimos datos sobre programa de recompra de acciones por valor de $5.000 millones

Gilead presenta ltimos datos sobre programa de recompra de acciones por valor de $5.000 millones


Published on 2010-09-01 10:10:35 - Market Wire
  Print publication without navigation


FOSTER CITY, California--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq:GILD) ha presentado informacin actualizada sobre el programa de recompra de acciones por valor de 5.000 millones de dlares anunciado anteriormente y autorizado por el Consejo de Administracin en mayo, 2010. Gilead ha recomprado aproximadamente $2.200 millones en acciones ordinarias durante este programa hasta el 31 de agosto, 2010.

Junto con el anuncio de la empresa de su oferta de deuda convertible el 26 de julio, 20010, Gilead ha adquirido desde entonces aproximadamente $1.000 millones de acciones recompradas a un precio medio de $33,68. La actividad de compras en el tercer trimestre es de aproximadamente $1.400 millones en acciones ordinarias.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Contributing Sources